Deletion of sequences in the 5' regulatory region.
Deficiency in 5' regulatory region.
Deletion in the 5' regulatory region.
Deficiency in 5' cis-regulatory region.
Deficiency in 5' cis regulatory region.
Deletion extending from nucleotide -1231 to -1115.
Deletion of 200bp between coordinates +5 and +5.9, using coordinate system of FBrf0038648 where coordinate 0 is the copia insert of wa.
deletion in regulatory region
Shows hyper-dosage compensation.
Testis colour: pigmentation enhanced.
wsp2 has abnormal eye color phenotype, enhanceable by z1
wsp2, zv77h has abnormal eye color phenotype, enhanceable by Taf91
wsp2, z1 has abnormal eye color phenotype, enhanceable by Taf91
wsp2, zv77h has abnormal eye color phenotype, enhanceable by e(y)21
wsp2, zv77h has abnormal eye color phenotype, enhanceable by e(y)34
wsp2, z1 has abnormal eye color phenotype, enhanceable by e(y)34
wsp2, zop6 has abnormal eye color phenotype, enhanceable by e(y)34
wsp2, zop6R1 has abnormal eye color phenotype, enhanceable by e(y)34
wsp2 has abnormal eye color phenotype, enhanceable by zv77h
wsp2 has abnormal eye color phenotype, non-enhanceable by Rga03834
wsp2, z1 has abnormal eye color phenotype, non-enhanceable by e(y)21
wsp2 has abnormal eye color phenotype, non-suppressible by Rga03834
wsp2, zv77h has pigment cell phenotype, enhanceable by Taf91
wsp2, z1 has pigment cell phenotype, enhanceable by Taf91
wsp2, zv77h has pigment cell phenotype, enhanceable by e(y)21
wsp2, zv77h has pigment cell phenotype, enhanceable by e(y)34
wsp2, z1 has pigment cell phenotype, enhanceable by e(y)34
wsp2, zop6 has pigment cell phenotype, enhanceable by e(y)34
wsp2, zop6R1 has pigment cell phenotype, enhanceable by e(y)34
wsp2 has pigment cell phenotype, enhanceable by zv77h
wsp2 has pigment cell phenotype, enhanceable by z1
wsp2 has phenotype, non-enhanceable by Kr-h105208
wsp2, z1 has pigment cell phenotype, non-enhanceable by e(y)21
sgl05007, wsp2 has pigment cell phenotype
Mohler, 22nd March 1956.